AMRZ
NYSE
$48.69
Amrize Ltd (AMRZ)
Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.
Sector:
Basic Materials
Industry:
Building Materials
Buy
Target: $63.16 (+29.73%)
Market Cap
$28B
Forward P/E
17.39
P/E Ratio
24.28
Free Cash Flow Yield
4.70%
Price Chart
Valuation
Market Cap$28B
P/E24.28
Forward P/E17.39
PEG1.34
P/S2.36
P/B2.10
Profitability
Total Revenue (TTM)$12B
Gross Profit (TTM)$3.02B
EBITDA$2.62B
Profit Margin-5.3%
Operating Margin-3.5%
EPS$2.09
Financial Health
Debt-to-Equity40.2%
Free Cash Flow Yield4.70%
Dividend Yield0.86%
Growth & Risk
Beta (5Y)1.30
Sharpe Ratio0.01